IBBL Biospecimen Proficiency Testing Programme Homepage



PT Program 2017

Dear PT Participant,

Thank you for participating in our 2017 PT programme, which includes 19 processing and testing schemes this year.
You can decide to participate in one or more schemes for 1, 2 or 3 consecutive years.

- CSF Aliquoting (NEW!)
- DNA quantification and purity
- RNA quantification and purity
- RNA integrity
- Cell viability
- Tissue histology
- Haemoglobin quantification in plasma
- Haemoglobin quantification in cerebrospinal fluid
- CD154 (CD40L) quantification in serum
- Viable PBMC isolation
- DNA extraction from whole blood
- RNA extraction from whole blood
- DNA extraction from FFPE cells
- RNA extraction from FFPE cells
- Microbial DNA extraction from saliva
- Microbial DNA extraction from stool
- DNA extraction from frozen tissue
- Total RNA extraction from frozen tissue
- Cell-free DNA (cfDNA) extraction from whole blood

Key dates to keep in mind:

May 2, 2017 - Registration opens online
August 11, 2017 - Registration closes
September , 2017 - Standardised samples will be shipped to your location
November, 2017 - Data submission deadline
February, 2018 - Your report(s) will be sent electronically

For more information, please visit or drop us an email on

IBBL (Integrated BioBank of Luxembourg)
For Next Generation Healthcare

6, rue Nicolas Ernest Barblé, L-1210, Luxembourg


Follow us | Facebook | Twitter | LinkedIn | Blog |

Data privacy
Pursuant to the Act of 2nd August 2002, relating to the protection of persons with respect to the treatment of personal data (“Loi du 2 août 2002 relative à la protection des personnes à l’égard du traitement des données à caractère personnel“,, the site user has in particular a right of access to, correction of and deletion of his personal data. The user may exercise these rights by sending a message to
The data collected on our site stem exclusively from the voluntary registering of your personal data, for example by subscribing to our Biospecimen Proficiency Testing programme.